DiogenX Funding: $35M Raised, Series A (2023)

DiogenX funding overview

DiogenX is based in Marseille, France. DiogenX has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for DiogenX runs through 2023; nothing later has been disclosed. Investors on record include Roche Venture Fund, Eli Lilly and Company, Omnes, Boehringer Ingelheim Venture Fund, JDRF T1D Fund. 5 distinct backers are named across the disclosed rounds.

DiogenX at a glance

Total raised: $35M
Latest round: Series A
Latest round date: January 2023
Headquarters: Marseille, France
Notable investors: Roche Venture Fund, Eli Lilly and Company, Omnes, Boehringer Ingelheim Venture Fund, JDRF T1D Fund

Frequently asked about DiogenX funding

How much has DiogenX raised?: DiogenX has raised $35M in total disclosed funding across the rounds on record.
Who has invested in DiogenX?: Roche Venture Fund, Eli Lilly and Company, Omnes, Boehringer Ingelheim Venture Fund, JDRF T1D Fund are named among the investors backing DiogenX.
What was the latest DiogenX funding round?: The most recent disclosed round is a Series A, announced in January 2023.
Where is DiogenX based?: DiogenX is based in Marseille, France.
When did DiogenX last raise?: The last disclosed DiogenX round closed in January 2023 at Series A.

Every DiogenX figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Marseille at a similar stage.

DiogenX Funding: $35M Raised, Series A (2023)

DiogenX funding overview

DiogenX at a glance

Frequently asked about DiogenX funding

Companies related to DiogenX (24)

Browse related funding lists (6)